To elucidate the molecular mechanisms underlying astrocyte dysfunction in fAD, MYC was selected as a central node for PPI analysis because it demonstrated strong activation (t = 4.73) in fAD astrocytes and the largest target network (886 target genes) among all assessed transcription factors (Fig. 3A). The gene discussed is MYC; the disease is familial Alzheimer disease.